Charles Ryan
President bei QUINCE THERAPEUTICS, INC.
Vermögen: 78 518 $ am 31.03.2024
Profil
Charles S.
Ryan is currently the Director at GlycoMira LLC and a Member at New York State Bar Association.
He is also the President at Quince Therapeutics, Inc. and a Trustee at The College of Wooster.
Previously, he served as the President, Chief Executive Officer & Director at Orthobond Corp., Chief Executive Officer & Director at Neurotrope, Inc., and Chief Executive Officer & Director at Synaptogenix, Inc. He was also the President, Chief Executive Officer & Director at Travecta Therapeutics Pte Ltd.
and Petros Pharmaceuticals, Inc. Additionally, he served as the Chairman-Development Council at Stony Brook University Medical Center, Independent Director at Applied DNA Sciences, Inc., Director at New York Biotechnology Association, Inc., and Independent Director at BioRestorative Therapies, Inc. He was also a Director at ABS Materials, Inc. and GlycoMira Therapeutics, Inc. Furthermore, he served as the Chief Intellectual Property Counsel & Senior VP at Forest Laboratories, Inc. and Vice President & General Counsel at Engelhard Long Island, Inc. He was also the Chief Operating Officer at LAB21, Inc. and Vice President & General Counsel at Cold Spring Harbor Laboratory, Inc. Dr. Ryan holds a doctorate degree from Stony Brook University, a graduate degree from Western New England University School of Law, and an undergraduate degree from The College of Wooster.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2024 | 74 074 ( 0,17% ) | 78 518 $ | 31.03.2024 |
Aktive Positionen von Charles Ryan
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | President | 01.09.2023 |
| GlycoMira LLC | Director/Board Member | - |
| The College of Wooster | Director/Board Member | - |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Charles Ryan
| Unternehmen | Position | Ende |
|---|---|---|
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Chief Executive Officer | 01.10.2022 |
| SYNAPTOGENIX, INC. | Chief Executive Officer | 01.12.2020 |
| NEUROTROPE, INC. | Chief Executive Officer | 01.12.2020 |
| BIORESTORATIVE THERAPIES, INC. | Director/Board Member | 10.01.2020 |
| APPLIED DNA SCIENCES, INC. | Director/Board Member | 07.11.2019 |
Ausbildung von Charles Ryan
| Stony Brook University | Doctorate Degree |
| Western New England University School of Law | Graduate Degree |
| The College of Wooster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| APPLIED DNA SCIENCES, INC. | Health Technology |
| BIORESTORATIVE THERAPIES, INC. | Health Technology |
| SYNAPTOGENIX, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| PETROS PHARMACEUTICALS | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Orthobond Corp.
 Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | Process Industries |
| GlycoMira LLC | |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Engelhard Long Island, Inc.
 Engelhard Long Island, Inc. Miscellaneous Commercial ServicesCommercial Services Engelhard Long Island, Inc. manufactured raw materials for the cosmetic and personal care industries. The company was founded by Joseph A. Twist in 1999 and was headquartered in Stony Brook, NY. | Commercial Services |
LAB21, Inc.
 LAB21, Inc. Medical/Nursing ServicesHealth Services Lab21, Inc. was engaged in providing laboratory testing services. The company was founded in 2001 and was headquartered in Greenville, SC . | Health Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
Cold Spring Harbor Laboratory, Inc.
 Cold Spring Harbor Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Cold Spring Harbor Laboratory, Inc. provides research services. It operates educational institutions. The firm offers research in cancer, neurobiology, plant genetics, and bioinformatics. It also offers laboratory workshops to science teachers, students, and other groups across the nation. The company was founded in 1890 and is headquartered in Cold Spring Harbor, NY. | Commercial Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Stony Brook University Medical Center
 Stony Brook University Medical Center Hospital/Nursing ManagementHealth Services Stony Brook University Medical Center operates a hospital. The non-profit company is based in Stony Brook, NY and has subsidiaries in United States. The CEO of the company is Carol Gomes. | Health Services |
ABS Materials, Inc.
 ABS Materials, Inc. Home FurnishingsConsumer Durables ABS Materials, Inc. develops reactive glass products and nanosands. Its BioMix-Osorb is a specialty, reductive soil media to accelerate plant growth, preserve healthy soil function, and protect surface water impacted by nonpoint/storm water pollution. The firm provides advanced material products and solutions to a variety of industries, including energy, manufacturing, agriculture, food and beverage, and chemical processing. The company was founded in December 2008 by Paul L. Edmiston and Stephen R. Spoonamore and is headquartered in Wooster, OH. | Consumer Durables |
Travecta Therapeutics Pte Ltd.
Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore. | Technology Services |
GlycoMira Therapeutics, Inc.
 GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Health Technology |
